Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy in the developing countries

P L Oei1, S S Ratnam

  • 1Department of Obstetrics and Gynaecology, National University of Singapore, Singapore.

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|July 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2001
Same author

Correlation of change in uterine activity to blood loss in the third stage of labour.

Gynecologic and obstetric investigation·1998
Same author

Arterial embolization for bleeding following hysterectomy for intractable postpartum hemorrhage.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1998
Same author

Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block.

Obstetrics and gynecology·1996
Same author

Maternal congenital heart disease and pregnancy outcome.

The journal of obstetrics and gynaecology research·1996
Same author

Role of transvaginal ultrasound color flow imaging and Doppler waveform analysis in differentiating between benign and malignant ovarian tumors.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·1996
Same journal

Obstetric Management and Outcomes for Women Living With HIV in Western Australia: A 30 Year Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Determining the Feasibility of a No-Ultrasound Screening Tool for Early Medical Abortion in Australia.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

'All In': Equitable Health Outcomes Require Culturally Safe Care for Everybody.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Benzylpenicillin Concentrations in Intrapartum Group B Streptococcus Prevention Guidelines; A Systematic Review of the Evidence.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Retrospective Cohort Study of Foetal Growth Restricted Births After 40 Weeks at an Australian Tertiary Maternity Hospital Between 2018 and 2021.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Models of Antenatal Care for Rural Indigenous Women: A Systematic Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
See all related articles

Sales of hormone replacement therapy (HRT) products are increasing in developing Asian countries. Despite variations in usage, HRT shows promising growth potential in these regions.

Area of Science:

  • Endocrinology
  • Pharmacoeconomics
  • Global Health

Background:

  • Hormone replacement therapy (HRT) is a critical treatment for postmenopausal women.
  • The adoption and sales trends of HRT in developing countries require examination.

Purpose of the Study:

  • To analyze the sales data of oestrogen replacement products in 8 developing Asian countries between 1993 and 1995.
  • To explore the reasons behind the increasing sales of hormone replacement products in these emerging markets.

Main Methods:

  • Analysis of sales data for oestrogen replacement products.
  • Comparative analysis of sales figures across different developing countries.

Main Results:

  • Sales data from Malaysia, Pakistan, Taiwan, Thailand, Indonesia, Philippines, and South Korea indicated a rise in oestrogen replacement product usage.

Related Experiment Videos

  • Significant variations in total usage were observed, ranging from US$11,153 (Philippines, 1993) to US$6,306,717 (Taiwan, 1995).
  • In Singapore, an established market, non-oestrogen replacement products also saw increased usage.

    • Conclusions:

    • Hormone replacement therapy is experiencing increasing adoption and sales in developing Asian countries.
    • The market for hormone replacement therapy in developing nations shows significant growth potential.
    • Factors contributing to increased HRT sales in these regions warrant further investigation.